Media & Research

This past Saturday, SYMBYX was featured in The Express UK; Parkinson’s (PD) is the world’s fastest growing neurodegenerative disease and second ...

A discussion on an integrated approach to managing Parkinson's with Special Guests and Panelists. Areas of Discussion: Navigating Dia...

      SYMBYX CEO, Dr Wayne Markman was hosted by Jessica Krauser and Brain Baker on their podcast series The Secret life of Parkinson's. The Secr...

      Description: Dr Roberta Chow, a world leading clinical practitioner and PhD in the field of laser therapy for pain management joined us ...

SYMBYX NEWS  Click here to read the latest SYMBYX news on light therapy. 1.  Rock 'n' Roll and Parkinson's. Q&A with former english musici...

     SYMBYX Webinar, 15th August. SYDNEY|TORONTO|DUBLIN. Wayne Markman, CEO of @SYMBYX Biome was joined by Orla Hares and Anita Saltmarche lead ...

   SYMBYX NEWS   Click here to read the latest SYMBYX news on light therapy. 1. Susie's Testimonial 2. SYMBYX in the Media 3. Lasers could help tre...

 Mater Research leads World-First Trial for Bowel Disease. 10 News Amanda Hart reports on the collaboration of Mater Research and SYMBYX, as they ...

Media release 2 June 2022 Mater Research leads world-first trial for bowel disease Mater Researchers are a step closer to discovering whether lase...

 SYMBYX announces two new clinical trials for Parkinson’s and a clear pathway seeking FDA approval     January 6, 2021 SYMBYX, an Australian medtec...

A TV story announcing a new trial of SYMBYX's PDCare Laser by Flinders University played on January 11 and 12 across Channel 7's Evening News as well as the Sunrise Morning Breakfast Program. This 6 month trial, based in Adelaide, South Australia, will include 36 participants divided into 3 groups. Some will use the equipment only, others will combine it with exercise, and the third group will be given fake equipment to monitor for placebo effects.